Comparative study of the efficacy of breast cancer neoadjuvant chemotherapy (NAC) in patients (pts) with BRCA1/2 mutation vs sporadic cancer cases versus pts with a family history but no BRCA1/2 mutation.
Francois P. Duhoux
No relevant relationships to disclose
Yann De Rycke
No relevant relationships to disclose
Marie-Christine Falcou
No relevant relationships to disclose
Francois-Clement Bidard
No relevant relationships to disclose
Youlia M. Kirova
No relevant relationships to disclose
Alexia Savignoni
No relevant relationships to disclose
Severine Alran
No relevant relationships to disclose
Jean-Yves Pierga
No relevant relationships to disclose
Bernard Asselain
No relevant relationships to disclose
Dominique Stoppa-Lyonnet
No relevant relationships to disclose
Anne De La Rochefordiere
No relevant relationships to disclose